Cancer Treatment

FDA Grants Early Access to Promising Pancreatic Cancer Drug Daraxonrasib

The FDA approves an expanded access program for daraxonrasib, an innovative pancreatic cancer drug that showed promising results in clinical trials, offering new hope for patients with one of the most challenging cancers.

Pancreatic Cancer mRNA Vaccine Shows Lasting Results in Early Trial, a Breakthrough in Decades

A pancreatic cancer mRNA vaccine has demonstrated lasting therapeutic effects in an early clinical trial, described by National Geographic as ’the biggest breakthrough in pancreatic cancer treatment in decades.'